Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

FATEFATE
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in FATE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 2M shares of FATE (FATE THERAPEUTICS INC), worth $5.5M as of 2026-Q2. The position was increased (+54.3% shares). FATE represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$5.5M

Current Shares

2M

Total Value Change

+$5.5M

Total Shares Change

+964,517

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+54.3%
$5.5M0.0%$2.70
38
2026-Q1
Decreased
1.3M
-7.5%
$1.6M0.0%$1.20
0
2025-Q4
Decreased
1.4M
-3.5%
$1.4M0.0%$0.98
0
2025-Q3
Decreased
1.5M
-40.8%
$1.9M0.0%$1.26
0
2025-Q2
Increased
2.5M
+2.1%
$2.8M0.0%$1.12
27
2025-Q1
Decreased
2.5M
-0.7%
$1.9M0.0%$0.79
0
2024-Q4
Decreased
2.5M
-12.3%
$4.1M0.0%$1.65
0
2024-Q3
Increased
2.8M
+20.2%
$9.9M0.0%$3.50
33
2024-Q2
Increased
2.3M
+16.7%
$7.7M0.0%$3.28
32
2024-Q1
Increased
2M
+240.5%
$14.8M0.0%$7.34
45
2023-Q4
Increased
590,993
+19.5%
$2.2M0.0%$3.74
31
2023-Q3
Decreased
494,466
-54.4%
$1M0.0%$2.12
0
2023-Q2
Decreased
1.1M
-18.4%
$5.2M0.0%$4.76
0
2023-Q1
Increased
1.3M
+64.0%
$7.6M0.0%$5.70
40
2022-Q4
Decreased
810,036
-22.2%
$8.2M0.0%$10.09
0
2022-Q3
Decreased
1M
-4.0%
$23,3450.0%$22.41
0
2022-Q2
First report
1.1M
-
$26,8790.0%$24.78
0

Other major holders of FATE: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used